Related references
Note: Only part of the references are listed.Outcome of 1000 Patients With Gastrointestinal Stromal Tumor (GIST) Treated by Surgery in the Pre- and Post-imatinib Eras
Michael J. Cavnar et al.
ANNALS OF SURGERY (2021)
Disease-free Interval Is Associated with Oncologic Outcomes in Patients with Recurrent Gastrointestinal Stromal Tumor
Thomas L. Sutton et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Metastatic pattern and prognosis of gastrointestinal stromal tumor (GIST): a SEER-based analysis
D. Y. Yang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Gastrointestinal stromal tumor (GIST) with liver metastases An 18-year experience from the GIST cooperation group in North China
Yi-Nan Shi et al.
MEDICINE (2017)
Resection of liver metastases in patients with gastrointestinal stromal tumors in the imatinib era: A nationwide retrospective study
M. F. J. Seesing et al.
EJSO (2016)
Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour
Ferdinando C. M. Cananzi et al.
ANZ JOURNAL OF SURGERY (2014)
Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era
Ryan S. Turley et al.
CANCER (2012)
Resection Combined with Imatinib Therapy for Liver Metastases of Gastrointestinal Stromal Tumors
Lin Xia et al.
SURGERY TODAY (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Molecular pathobiology of gastrointestinal stromal sarcomas
Christopher L. Corless et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Results of tyrosine-kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor
Ronald P. DeMatteo et al.
ANNALS OF SURGERY (2007)
Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors
Chandrajit P. Raut et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)